Confirman el síndrome de Guillain-Barré como un efecto secundario de la vacuna de AstraZeneca | DiarioMedico
Could the AstraZeneca vaccine cause Guillain-Barré syndrome? We don't know yet — but there's minimal cause for concern
Diagnosis and management of Guillain–Barré syndrome in ten steps | Nature Reviews Neurology
Johnson & Johnson vaccine and Guillain-Barré: FDA adds new warning related to rare autoimmune disorder - The Washington Post
Sociedad Española de Trombosis y Hemostasia - Nota de seguridad de la AEMPS referente a «Vaxzevria (vacuna frente a la COVID-19 de AstraZeneca) y riesgo de síndrome de Guillain-Barré». Leer nota 👉
Guillain-Barre syndrome following the first dose of the chimpanzee adenovirus-vectored COVID-19 vaccine, ChAdOx1 | BMJ Case Reports
Síndrome Guillain-Barré: qué es y cómo se relaciona con las vacunas | Ecología | La Revista | El Universo
Guillain-Barre syndrome: An autoimmune disorder post-COVID-19 vaccination? - ScienceDirect
Guillain-Barré Syndrome Treatment
Miller Fisher syndrome following BNT162b2 mRNA coronavirus 2019 vaccination | BMC Neurology | Full Text
Rise in Guillain-Barré syndrome following AstraZeneca vaccine | UCL News - UCL – University College London
J&J Covid-19 vaccine may trigger neurological condition in rare cases
EU reviews reports of rare nerve disorder after AstraZeneca's COVID-19 shot | Reuters
Síndrome de Guillain-Barré: el trastorno neurológico que afecta a algunas personas vacunadas contra el coronavirus - BBC News Mundo
FDA Warns About Post-COVID Vax Guillain-Barré Syndrome | MedPage Today
Vacuna de AstraZeneca: regulador europeo pide estar alerta a signos de síndrome de Guillain-Barré – El Financiero
Case reports describe 'unusual' Guillain-Barre variants following COVID-19 vaccination
Vacuna de Astra: confirman que el síndrome Guillain-Barré es efecto secundario poco usual – El Financiero
Syndrome de Guillain-Barré | Effet secondaire « très rare » du vaccin AstraZeneca | La Presse
Statement of the WHO Global Advisory Committee on Vaccine Safety (GACVS) COVID-19 subcommittee on reports of Guillain-Barré Syndrome (GBS) following adenovirus vector COVID-19 vaccines
Diagnosis and management of Guillain–Barré syndrome in ten steps | Nature Reviews Neurology
Johnson & Johnson vaccine increases risk of rare nerve disorder, US FDA warns
Qué es el síndrome de Guillain-Barré y cómo se relaciona con las vacunas de J&J y AstraZeneca? - Covid-19: Consulta con el Médico
Unusual Variant of Guillain-Barré Syndrome Linked to COVID Vaccines | MedPage Today
Frontiers | Guillain–Barré Syndrome and Variants Following COVID-19 Vaccination: Report of 13 Cases
Guillain-Barré syndrome after COVID-19 vaccination | BMJ Case Reports